Fred Hutch Logo

Publications

Complete Bibliography

Visit PubMed to view Dr. Christopher Li's complete publications record.

2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 and earlier

2020

Jarvik GP, Wang X, Fontanillas P, et al. Hemochromatosis risk genotype is not associated with colorectal cancer risk or age of onset. Am J Human Genetics, submitted.

Hughye JR, Harrison TA, Bien SA, et al. Genetic architectures of proximal and distal colorectal cancer are partly distinct. Gut, in press.

Biltaji E, Walker B, Au TH, Ose J, Li CI, Brixner D, Stenehjem DD, Ulrich CM. Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention? Cancer Epidemiol Biomarker Prev, submitted.

Nounu A, Greenhough A, Heesom KJ, Richmond RC, Zheng J, Weinstein SJ, Albanes D, Baron JA, Hopper JL, Figueiredo JC, Newcomb PA, Lindor NM, Casey G, Platz EA, Le Marchand L, Ulrich CM, Li CI, van Duijnhoven FJB, Gsur A, Campbell P, Moreno V, Vodicka P, Vodickova L, Brenner H, Chang-Claude J, Hoffmeister M, Sakoda LC, Slattery ML, Schoen RE, Gunter MJ, Castellví-Bel S, Kim HR, Kweon SS, Chan AT, Li L, Zheng W, Bishop DT, Buchanan DD, Giles GG, Gruber SB, Rennert G, Stadler ZK, Harrison TA, Lin Y, Keku TO, Woods MO, Schafmayer C, Van Guelpen B, Gallinger S, Hampel H, Berndt SI, Pharoah PDP, Lindblom A, Wolk A, Wu AH, White E, Peters U, Drew DA, Scherer D, Bermejo JL, Williams AC, Relton CL. A combined proteomics and Mendelian randomization approach to investigate the effects of aspirin-targeted proteins on colorectal cancer. Cancer Epidemiol Biomarkers Prev 2020:cebp.1176.2020.

Tran Q, Warren JL, Barrett MJ, Annett D, Marth M, Cress RD, Deapen D, Glaser SL, Gomez SL, Schwartz SM, Li CI, Wu XC, Enewold L, Harlan LC, Rivera DR, Winn DM, Penberthy L, Cronin KA.
An Evaluation of the Utility of Big Data to Supplement Cancer Treatment Information: Linkage Between IQVIA Pharmacy Database and the Surveillance, Epidemiology, and End Results Program. J Natl Cancer Inst Monogr 2020;2020(55):72-81.

Bull CJ, Bell JA, Murphy N, Sanderson E, Davey Smith G, Timpson NJ, Banbury BL, Albanes D, Berndt SI, Bézieau S, Bishop DT, Brenner H, Buchanan DD, Burnett-Hartman A, Casey G, Castellví-Bel S, Chan AT, Chang-Claude J, Cross AJ, de la Chapelle A, Figueiredo JC, Gallinger SJ, Gapstur SM, Giles GG, Gruber SB, Gsur A, Hampe J, Hampel H, Harrison TA, Hoffmeister M, Hsu L, Huang WY, Huyghe JR, Jenkins MA, Joshu CE, Keku TO, Kühn T, Kweon SS, Le Marchand L, Li CI, Li L, Lindblom A, Martín V, May AM, Milne RL, Moreno V, Newcomb PA, Offit K, Ogino S, Phipps AI, Platz EA, Potter JD, Qu C, Quirós JR, Rennert G, Riboli E, Sakoda LC, Schafmayer C, Schoen RE, Slattery ML, Tangen CM, Tsilidis KK, Ulrich CM, van Duijnhoven FJB, van Guelpen B, Visvanathan K, Vodicka P, Vodickova L, Wang H, White E, Wolk A, Woods MO, Wu AH, Campbell PT, Zheng W, Peters U, Vincent EE, Gunter MJ. Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study. BMC Med 2020;18(1):396.

Geijsen AJMR, Ulvik A, Gigic B, Kok DE, van Duijnhoven FJB, Holowatyj AN, Brezina S, van Roekel EH, Baierl A, Bergmann MM, Böhm J, Bours MJL, Brenner H, Breukink SO, Bronner MP, Chang-Claude J, de Wilt JHW, Grady WM, Grünberger T, Gumpenberger T, Herpel E, Hoffmeister M, Huang LC, Jedrzkiewicz JD, Keulen ETP, Kiblawi R, Kölsch T, Koole JL, Kosma K, Kouwenhoven EA, Kruyt FM, Kvalheim G, Li CI, Lin T, Ose J, Pickron TB, Scaife CL, Schirmacher P, Schneider MA, Schrotz-King P, Singer MC, Swanson ER, van Duijvendijk P, van Halteren HK, van Zutphen M, Vickers K, Vogelaar FJ, Wesselink E, Habermann N, Ulrich AB, Ueland PM, Weijenberg MP, Gsur A, Ulrich CM, Kampman E. Circulating folate and folic acid concentrations: associations with colorectal cancer recurrence and survival. JNCI Cancer Spectr 2020;4(5):pkaa051.

Gigic B, Nattenmüller J, Schneider M, Kulu Y, Syrjala K, Böhm J, Schrotz-King P, Brenner H, Colditz GA, Figueiredo JC, Grady WM, Li CI, Shibata D, Siegel EM, Toriola AT, Kauczor H-U, Ulrich A, Ulrich CM. The role of CT-quantified body composition on longitudinal health-related quality of life in colorectal cancer patients: the ColoCare Study. Nutrients 2020;12(5):1247.

Viskochil R, Gigic B, Lin T, Skender S, Böhm J, Schrotz-King P, Steindorf K, Owen R, Figueiredo JC, Li CI, Siegel EM, Hardikar S, Shibata D, Toriola AT, Schneider M, Ulrich A, Ulrich CM, Ose J. Associations between physical activity, sedentary behavior and urinary oxidized guanine in colorectal cancer patients: Results from the ColoCare Study. Applied Physiology, Nutrition, and Metabolism 2020;45(11):1306-1309.

Chen H, Yaghjyan L, Li CI, Peters U, Rosner B, Lindstrom S, Tamini RM. Interactions between mammographic density phenotypes and established risk factors on breast cancer risk by tumor subtype and menopausal status. Am J Epidemiol 2020, in press.

McDougall JA, Cook LS, Tang MC, Linden HM, Thompson B, Li CI. Determinants of guideline-discordant breast cancer care. Cancer Epidemiol Biomarkers Prev 2020 Oct 22. doi: 10.1158/1055-9965.EPI-20-0985.

Han CJ, Gigic B, Schneider M, Kulu Y, Peoples AR, Ose J, Kolsch T, Jacobsen PB, Colditz GA, Figueiredo JC, Grady WM, Li CI, Shibata D, Siegel EM, Toriola AT, Ulrich AB, Syrjala KL, Ulrich CM. J Cancer Survivorship 2020;14(3):305-315.

Corley DA, Sedki M, Ritzwoller DP, Greenlee RT, Neslund-Dudas C, Rendle KA, Honda SA, Schottinger JE, Udaltsova N, Vachani A, Kobrin S, Li CI, Haas JS.
Cancer Screening during COVID-19: A Perspective from NCI's PROSPR consortium. Gastroenterology. 2020 Oct 21:S0016-5085(20)35317-8.

Thomas M, Sakoda LC, Hoffmeister M, Rosenthal EA, Lee JK, van Duijnhoven FJB, Platz EA, Wu AH, Dampier CH, de la Chapelle A, Wolk A, Joshi AD, Burnett-Hartman A, Gsur A, Lindblom A, Castells A, Win AK, Namjou B, Van Guelpen B, Tangen CM, He Q, Li CI, Schafmayer C, Joshu CE, Ulrich CM, Bishop DT, Buchanan DD, Schaid D, Drew DA, Muller DC, Duggan D, Crosslin DR, Albanes D, Giovannucci EL, Larson E, Qu F, Mentch F, Giles GG, Hakonarson H, Hampel H, Stanaway IB, Figueiredo JC, Huyghe JR, Minnier J, Chang-Claude J, Hampe J, Harley JB, Visvanathan K, Curtis KR, Offit K, Li L, Le Marchand L, Vodickova L, Gunter MJ, Jenkins MA, Slattery ML, Lemire M, Woods MO, Song M, Murphy N, Lindor NM, Dikilitas O, Pharoah PDP, Campbell PT, Newcomb PA, Milne RL, MacInnis RJ, Castellví-Bel S, Ogino S, Berndt SI, Bézieau S, Thibodeau SN, Gallinger SJ, Zaidi SH, Harrison TA, Keku TO, Hudson TJ, Vymetalkova V, Moreno V, Martín V, Arndt V, Wei WQ, Chung W, Su YR, Hayes RB, White E, Vodicka P, Casey G, Gruber SB, Schoen RE, Chan AT, Potter JD, Brenner H, Jarvik GP, Corley DA, Peters U, Hsu L. Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk. Am J Hum Genet 2020 Sep 3;107(3):432-444.

Seyed Khoei N, Jenab M, Murphy N, Banbury BL, Carreras-Torres R, Viallon V, Kühn T, Bueno-de-Mesquita B, Aleksandrova K, Cross AJ, Weiderpass E, Stepien M, Bulmer A, Tjønneland A, Boutron-Ruault MC, Severi G, Carbonnel F, Katzke V, Boeing H, Bergmann MM, Trichopoulou A, Karakatsani A, Martimianaki G, Palli D, Tagliabue G, Panico S, Tumino R, Sacerdote C, Skeie G, Merino S, Bonet C, Rodríguez-Barranco M, Gil L, Chirlaque MD, Ardanaz E, Myte R, Hultdin J, Perez-Cornago A, Aune D, Tsilidis KK, Albanes D, Baron JA, Berndt SI, Bézieau S, Brenner H, Campbell PT, Casey G, Chan AT, Chang-Claude J, Chanock SJ, Cotterchio M, Gallinger S, Gruber SB, Haile RW, Hampe J, Hoffmeister M, Hopper JL, Hsu L, Huyghe JR, Jenkins MA, Joshi AD, Kampman E, Larsson SC, Le Marchand L, Li CI, Li L, Lindblom A, Lindor NM, Martín V, Moreno V, Newcomb PA, Offit K, Ogino S, Parfrey PS, Pharoah PDP, Rennert G, Sakoda LC, Schafmayer C, Schmit SL, Schoen RE, Slattery ML, Thibodeau SN, Ulrich CM, van Duijnhoven FJB, Weigl K, Weinstein SJ, White E, Wolk A, Woods MO, Wu AH, Zhang X, Ferrari P, Anton G, Peters A, Peters U, Gunter MJ, Wagner KH, Freisling H. Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses. BMC Med 2020;18(1):229.

Khankari NK, Banbury BL, Borges MC, Haycock P, Albanes D, Arndt V, Berndt SI, Bézieau S, Brenner H, Campbell PT, Casey G, Chan AT, Chang-Claude J, Conti DV, Cotterchio M, English DR, Figueiredo JC, Giles GG, Giovannucci EL, Gunter MJ, Hampe J, Hoffmeister M, Hopper JL, Jenkins MA, Joshi AD, Marchand LL, Lemire M, Li CI, Li L, Lindblom A, Martín V, Moreno V, Newcomb PA, Offit K, Pharoah PDP, Rennert G, Sakoda LC, Schafmayer C, Schmit SL, Slattery ML, Song M, Thibodeau SN, Ulrich CM, Weinstein SJ, White E, Win AK, Wolk A, Woods MO, Wu AH, Cai Q, Denny JC, Edwards TL, Murff HJ, Gruber SB, Peters U, Zheng W. Mendelian randomization of circulating polysaturated fatty acids and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2020;29:860-870.

Papadimitriou N, Dimou N, Tsilidis KK, Banbury B, Martin RM, Lewis SJ, Kazmi N, Robinson TM, Albanes D, Aleksandrova K, Berndt SI, Timothy Bishop D, Brenner H, Buchanan DD, Bueno-de-Mesquita B, Campbell PT, Castellví-Bel S, Chan AT, Chang-Claude J, Ellingjord-Dale M, Figueiredo JC, Gallinger SJ, Giles GG, Giovannucci E, Gruber SB, Gsur A, Hampe J, Hampel H, Harlid S, Harrison TA, Hoffmeister M, Hopper JL, Hsu L, María Huerta J, Huyghe JR, Jenkins MA, Keku TO, Kühn T, La Vecchia C, Le Marchand L, Li CI, Li L, Lindblom A, Lindor NM, Lynch B, Markowitz SD, Masala G, May AM, Milne R, Monninkhof E, Moreno L, Moreno V, Newcomb PA, Offit K, Perduca V, Pharoah PDP, Platz EA, Potter JD, Rennert G, Riboli E, Sánchez MJ, Schmit SL, Schoen RE, Severi G, Sieri S, Slattery ML, Song M, Tangen CM, Thibodeau SN, Travis RC, Trichopoulou A, Ulrich CM, van Duijnhoven FJB, Van Guelpen B, Vodicka P, White E, Wolk A, Woods MO, Wu AH, Peters U, Gunter MJ, Murphy N. Physical activity and risks of breast anc colorectal cancer: a Mendelian randomisation analysis. Nat Commun. 2020 Jan 30;11(1):597. doi: 10.1038/s41467-020-14389-8.

Wang T, Maden SK, Luebeck GE, Li CI, Newcomb PA, Ulrich CM, Joo JE, Buchanan DD, Milne RL, Southey MC, Carter KT, Willbanks AR, Luo Y, Yu M, Grady WM. Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk. Clin Epigenetics 2020;12:5.

Murphy N, Carreras-Torres R, Song M, Chan AT, Martin RM, Papadimitriou N, Dimou N, Tsilidis KK, Banbury B, Bradbury KE, Besevic J, Rinaldi S, Riboli E, Cross AJ, Travis RC, Agnoli C, Albanes D, Berndt SI, Bézieau S, Bishop DT, Brenner H, Buchanan DD, Onland-Moret NC, Burnett-Hartman A, Campbell PT, Casey G, Castellví-Bel S, Chang-Claude J, Chirlaque MD, de la Chapelle A, English D, Figueiredo JC, Gallinger SJ, Giles GG, Gruber SB, Gsur A, Hampe J, Hampel H, Harrison TA, Hoffmeister M, Hsu L, Huang WY, Huyghe JR, Jenkins MA, Keku TO, Kühn T, Kweon SS, Le Marchand L, Li CI, Li L, Lindblom A, Martín V, Milne RL, Moreno V, Newcomb PA, Offit K, Ogino S, Ose J, Perduca V, Phipps AI, Platz EA, Potter JD, Qu C, Rennert G, Sakoda LC, Schafmayer C, Schoen RE, Slattery ML, Tangen CM, Ulrich CM, van Duijnhoven FJB, Van Guelpen B, Visvanathan K, Vodicka P, Vodickova L, Vymetalkova V, Wang H, White E, Wolk A, Woods MO, Wu AH, Zheng W, Peters U, Gunter MJ. Circulating levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 associate with risk of colorectal cancer based on serologic and Medelian randomization analyses. Gastroenterology 2020;158:1300-1312.

Archambault AN, Su YR, Jeon J, Thomas M, Lin Y, Conti DV, Win AK, Sakoda LC, Lansdorp-Vogelaar I, Peterse EFP, Zauber AG, Duggan D, Holowatyj AN, Huyghe JR, Brenner H, Cotterchio M, Bézieau S, Schmit SL, Edlund CK, Southey MC, MacInnis RJ, Campbell PT, Chang-Claude J, Slattery ML, Chan AT, Joshi AD, Song M, Cao Y, Woods MO, White E, Weinstein SJ, Ulrich CM, Hoffmeister M, Bien SA, Harrison TA, Hampe J, Li CI, Schafmayer C, Offit K, Pharoah PD, Moreno V, Lindblom A, Wolk A, Wu AH, Li L, Gunter MJ, Gsur A, Keku TO, Pearlman R, Bishop DT, Castellví-Bel S, Moreira L, Vodicka P, Kampman E, Giles GG, Albanes D, Baron JA, Berndt SI, Brezina S, Buch S, Buchanan DD, Trichopoulou A, Severi G, Chirlaque MD, Sánchez MJ, Palli D, Kühn T, Murphy N, Cross AJ, Burnett-Hartman AN, Chanock SJ, de la Chapelle A, Easton DF, Elliott F, English DR, Feskens EJM, FitzGerald LM, Goodman PJ, Hopper JL, Hudson TJ, Hunter DJ, Jacobs EJ, Joshu CE, Küry S, Markowitz SD, Milne RL, Platz EA, Rennert G, Rennert HS, Schumacher FR, Sandler RS, Seminara D, Tangen CM, Thibodeau SN, Toland AE, van Duijnhoven FJB, Visvanathan K, Vodickova L, Potter JD, Männistö S, Weigl K, Figueiredo J, Martín V, Larsson SC, Parfrey PS, Huang WY, Lenz HJ, Castelao JE, Gago-Dominguez M, Muñoz-Garzón V, Mancao C, Haiman CA, Wilkens LR, Siegel E, Barry E, Younghusband B, Van Guelpen B, Harlid S, Zeleniuch-Jacquotte A, Liang PS, Du M, Casey G, Lindor NM, Le Marchand L, Gallinger SJ, Jenkins MA, Newcomb PA, Gruber SB, Schoen RE, Hampel H, Corley DA, Hsu L, Peters U, Hayes RB. Cumulative burden of colorectal cancer-associated genetic variants is more strongly associated with early-onset vs late-onset cancer. Gastroenterology 2020;158:1274-1286.

Ma KK, Preusse CJ, Stevenson PA, Winget VL, McDougall JA, Li CI, Gadi VK, Gammill HS. Obstetric outcomes in young women with breast cancer: prior, postpartum, and subsequent pregnancies. Am J Perinatol 2020;37:370-374.

2019

Breen N, Skinner CS, Zheng Y, Inrig S, Corley DA, Beaber EF, Garcia M, Chubak J, Doubeni C, Quinn VP, Haas JS, Li CI, Wernli KJ, Klabunde CN; PROSPR consortium. Time to follow-up after colorectal cancer screening by health insurance type. Am J Prev Med 2019;56:e143-e152.

Ose J, Gigic B, Lin T, Liesenfeld DB, Boehm J, Nattenmueller J, Scherer D, Zielske L, Schrotz-King P, Habermann N, Ochs-Balcom HM, Peoples AR, Hardikar S, Li CI, Shibata D, Figueiredo J, Torioloa AT, Siegal EM, Schmit S, Schneider M, Ulrich A, Kauczor H-M, Ulrich C. Multiplatform urinary metabolomics profiling to discriminate cachectic from non-cachectic colorectal cancer patients: Pilot results from the ColoCare Study. Metabolites 2019;9(9). pii: E178. doi: 10.3390/metabo9090178.

Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiologic evidence. Lancet 2019;394:1159-1168.

Guo Y, Ayers JL, Carter KT, Wang T, Maden SK, Edmonds D, Newcomb PP, Li CI, Ulrich C, Yu M, Grady WM. Senescence-associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15. Aging Cell 2019;18:e13013. doi: 10.1111/acel.13013.

Chen H, Cook LS, Tang MC, Hill DA, Wiggins CL, Li CI. Relationship between diabetes and diabetes medications and risk of different molecular subtypes of breast cancer. Cancer Epidemiol Biomarker Prev, 2019;28:1802-1808.

Lorona NC, Cook LS, Tang MC, Hill DA, Wiggins CL, Li CI. Recent use of oral contraceptives and risk of luminal B, triple-negative, and HER2-overexpressing breast cancer. Horm Cancer 2019;10:71-76.

Niu X, Li CI, Mueller BA. Obstetrical and infant outcomes among women with neoplasms during pregnancy. Cancer Causes Control 2019;30:651-661.

Conant EF, Barlow WE, Herschorn SD, Weaver DL, Beaber EF, Tosteson ANA, Haas JS, Lowry KP, Stout NK, Trentham-Dietz A, diFlorio-Alexander RM, Li CI, Schnall MD, Onega T, Sprague BL. Association of digital breast tomosynthesis vs digital mammography with cancer detection and recall rates by age and breast density. JAMA Oncology 2019;5:635-642.

Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, Aldrich MC, Andrew AS, Andrulis IL, Anton-Culver H, Antoniou AC, Antonenkova NN, Arnold SM, Aronson KJ, Arun BK, Bandera EV, Barkardottir RB, Barnes DR, Batra J, Beckmann MW, Benitez J, Benlloch S, Berchuck A, Berndt SI, Bickeböller H, Bien SA, Blomqvist C, Boccia S, Bogdanova NV, Bojesen SE, Bolla MK, Brauch H, Brenner H, Brenton JD, Brook MN, Brunet J, Brunnström H, Buchanan DD, Burwinkel B, Butzow R, Cadoni G, Caldés T, Caligo MA, Campbell I, Campbell PT, Cancel-Tassin G, Cannon-Albright L, Campa D, Caporaso N, Carvalho AL, Chan AT, Chang-Claude J, Chanock SJ, Chen C, Christiani DC, Claes KBM, Claessens F, Clements J, Collée JM, Correa MC, Couch FJ, Cox A, Cunningham JM, Cybulski C, Czene K, Daly MB, deFazio A, Devilee P, Diez O, Gago-Dominguez M, Donovan JL, Dörk T, Duell EJ, Dunning AM, Dwek M, Eccles DM, Edlund CK, Edwards DRV, Ellberg C, Evans DG, Fasching PA, Ferris RL, Liloglou T, Figueiredo JC, Fletcher O, Fortner RT, Fostira F, Franceschi S, Friedman E, Gallinger SJ, Ganz PA, Garber J, García-Sáenz JA, Gayther SA, Giles GG, Godwin AK, Goldberg MS, Goldgar DE, Goode EL, Goodman MT, Goodman G, Grankvist K, Greene MH, Gronberg H, Gronwald J, Guénel P, Håkansson N, Hall P, Hamann U, Hamdy FC, Hamilton RJ, Hampe J, Haugen A, Heitz F, Herrero R, Hillemanns P, Hoffmeister M, Høgdall E, Hong YC, Hopper JL, Houlston R, Hulick PJ, Hunter DJ, Huntsman DG, Idos G, Imyanitov EN, Ingles SA, Isaacs C, Jakubowska A, James P, Jenkins MA, Johansson M, Johansson M, John EM, Joshi AD, Kaneva R, Karlan BY, Kelemen LE, Kühl T, Khaw KT, Khusnutdinova E, Kibel AS, Kiemeney LA, Kim J, Kjaer SK, Knight JA, Kogevinas M, Kote-Jarai Z, Koutros S, Kristensen VN, Kupryjanczyk J, Lacko M, Lam S, Lambrechts D, Landi MT, Lazarus P, Le ND, Lee E, Lejbkowicz F, Lenz HJ, Leslie G, Lessel D, Lester J, Levine DA, Li L, Li CI, Lindblom A, Lindor NM, Liu G, Loupakis F, Lubiński J, Maehle L, Maier C, Mannermaa A, Marchand LL, Margolin S, May T, McGuffog L, Meindl A, Middha P, Miller A, Milne RL, MacInnis RJ, Modugno F, Montagna M, Moreno V, Moysich KB, Mucci L, Muir K, Mulligan AM, Nathanson KL, Neal DE, Ness AR, Neuhausen SL, Nevanlinna H, Newcomb PA, Newcomb LF, Nielsen FC, Nikitina-Zake L, Nordestgaard BG, Nussbaum RL, Offit K, Olah E, Olama AAA, Olopade OI, Olshan AF, Olsson H, Osorio A, Pandha H, Park JY, Pashayan N, Parsons MT, Pejovic T, Penney KL, Peters WHM, Phelan CM, Phipps AI, Plaseska-Karanfilska D, Pring M, Prokofyeva D, Radice P, Stefansson K, Ramus SJ, Raskin L, Rennert G, Rennert HS, van Rensburg EJ, Riggan MJ, Risch HA, Risch A, Roobol MJ, Rosenstein BS, Rossing MA, De Ruyck K, Saloustros E, Sandler DP, Sawyer EJ, Schabath MB, Schleutker J, Schmidt MK, Setiawan VW, Shen H, Siegel EM, Sieh W, Singer CF, Slattery ML, Sorensen KD, Southey MC, Spurdle AB, Stanford JL, Stevens VL, Stintzing S, Stone J, Sundfeldt K, Sutphen R, Swerdlow AJ, Tajara EH, Tangen CM, Tardon A, Taylor JA, Teare MD, Teixeira MR, Terry MB, Terry KL, Thibodeau SN, Thomassen M, Bjørge L, Tischkowitz M, Toland AE, Torres D, Townsend PA, Travis RC, Tung N, Tworoger SS, Ulrich CM, Usmani N, Vachon CM, Van Nieuwenhuysen E, Vega A, Aguado-Barrera ME, Wang Q, Webb PM, Weinberg CR, Weinstein S, Weissler MC, Weitzel JN, West CML, White E, Whittemore AS, Wichmann HE, Wiklund F, Winqvist R, Wolk A, Woll P, Woods M, Wu AH, Wu X, Yannoukakos D, Zheng W, Zienolddiny S, Ziogas A, Zorn KK, Lane JM, Saxena R, Thomas D, Hung RJ, Diergaarde B, McKay J, Peters U, Hsu L, García-Closas M, Eeles RA, Chenevix-Trench G, Brennan PJ, Haiman CA, Simard J, Easton DF, Gruber SB, Pharoah PDP, Price AL, Pasaniuc B, Amos CI, Kraft P, Lindström S. Shared heritability and functional enrichment across six solid cancers. Nature Communications 2019;10:431. doi: 10.1038/s41467-018-08054-4.

Bien SA, Su YR, Conti DV, Harrison TA, Qu C, Guo X, Lu Y, Albanes D, Auer PL, Banbury BL, Berndt SI, Bézieau S, Brenner H, Buchanan DD, Caan BJ, Campbell PT, Carlson CS, Chan AT, Chang-Claude J, Chen S, Connolly CM, Easton DF, Feskens EJM, Gallinger S, Giles GG, Gunter MJ, Hampe J, Huyghe JR, Hoffmeister M, Hudson TJ, Jacobs EJ, Jenkins MA, Kampman E, Kang HM, Kühn T, Küry S, Lejbkowicz F, Le Marchand L, Milne RL, Li L, Li CI, Lindblom A, Lindor NM, Martín V, McNeil CE, Melas M, Moreno V, Newcomb PA, Offit K, Pharaoh PDP, Potter JD, Qu C, Riboli E, Rennert G, Sala N, Schafmayer C, Scacheri PC, Schmit SL, Severi G, Slattery ML, Smith JD, Trichopoulou A, Tumino R, Ulrich CM, van Duijnhoven FJB, Van Guelpen B, Weinstein SJ, White E, Wolk A, Woods MO, Wu AH, Abecasis GR, Casey G, Nickerson DA, Gruber SB, Hsu L, Zheng W, Peters U. Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer. Human Genetics 2019;138:307-326.

Huyghe JR, Bien SA, Harrison TA, Kang HM, Chen S, Schmit SL, Conti DV, Qu C, Jeon J, Edlund CK, Greenside P, Wainberg M, Schumacher FR, Smith JD, Levine DM, Nelson SC, Sinnott-Armstrong NA, Albanes D, Alonso MH, Anderson K, Arnau-Collell C, Arndt V, Bamia C, Banbury BL, Baron JA, Berndt SI, Bézieau S, Bishop DT, Boehm J, Boeing H, Brenner H, Brezina S, Buch S, Buchanan DD, Burnett-Hartman A, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Castellví-Bel S, Chan AT, Chang-Claude J, Chanock SJ, Chirlaque MD, Cho SH, Connolly CM, Cross AJ, Cuk K, Curtis KR, de la Chapelle A, Doheny KF, Duggan D, Easton DF, Elias SG, Elliott F, English DR, Feskens EJM, Figueiredo JC, Fischer R, FitzGerald LM, Forman D, Gala M, Gallinger S, Gauderman WJ, Giles GG, Gillanders E, Gong J, Goodman PJ, Grady WM, Grove JS, Gsur A, Gunter MJ, Haile RW, Hampe J, Hampel H, Harlid S, Hayes RB, Hofer P, Hoffmeister M, Hopper JL, Hsu WL, Huang WY, Hudson TJ, Hunter DJ, Ibañez-Sanz G, Idos GE, Ingersoll R, Jackson RD, Jacobs EJ, Jenkins MA, Joshi AD, Joshu CE, Keku TO, Key TJ, Kim HR, Kobayashi E, Kolonel LN, Kooperberg C, Kühn T, Küry S, Kweon SS, Larsson SC, Laurie CA, Le Marchand L, Leal SM, Lee SC, Lejbkowicz F, Lemire M, Li CI, Li L, Lieb W, Lin Y, Lindblom A, Lindor NM, Ling H, Louie TL, Männistö S, Markowitz SD, Martín V, Masala G, McNeil CE, Melas M, Milne RL, Moreno L, Murphy N, Myte R, Naccarati A, Newcomb PA, Offit K, Ogino S, Onland-Moret NC, Pardini B, Parfrey PS, Pearlman R, Perduca V, Pharoah PDP, Pinchev M, Platz EA, Prentice RL, Pugh E, Raskin L, Rennert G, Rennert HS, Riboli E, Rodríguez-Barranco M, Romm J, Sakoda LC, Schafmayer C, Schoen RE, Seminara D, Shah M, Shelford T, Shin MH, Shulman K, Sieri S, Slattery ML, Southey MC, Stadler ZK, Stegmaier C, Su YR, Tangen CM, Thibodeau SN, Thomas DC, Thomas SS, Toland AE, Trichopoulou A, Ulrich CM, Van Den Berg DJ, van Duijnhoven FJB, Van Guelpen B, van Kranen H, Vijai J, Visvanathan K, Vodicka P, Vodickova L, Vymetalkova V, Weigl K, Weinstein SJ, White E, Win AK, Wolf CR, Wolk A, Woods MO, Wu AH, Zaidi SH, Zanke BW, Zhang Q, Zheng W, Scacheri PC, Potter JD, Bassik MC, Kundaje A, Casey G, Moreno V, Abecasis GR, Nickerson DA, Gruber SB, Hsu L, Peters U. Discovery of common and rare genetic risk variants for colorectal cancer. Nature Genetics 2019;51:76-87.

Luebeck GE, Hazelton WD, Curtius K, Maden SK, Yu M, Carter KT, Burke W, Lampe PD, Li CI, Ulrich CM, Newcomb PA, Westerhoff M, Kaz AM, Luo Y, Inadomi JM, Grady WM. Implications of epigenetic drift in colorectal neoplasia. Cancer Research 2019;79:495-504.

Ulrich CM, Gigic B, Bohm J, Ose J, Viskochil R, Schneider M, Colditz GA, Figueiredo JC, Grady WM, Li CI, Shibata D, Siegel EM, Toriola AT, Ulrich A. The ColoCare Study: A paradigm of transdisciplinary science in colorectal cancer outcomes. Cancer Epidemiol Biomarker Prev 2019;28:591-601.

Baglia ML, Tang MC, Malone KE, Porter P, Li CI. Reproductive and menopausal factors and risk of second primary breast cancer after in situ breast carcinoma. Cancer Causes Control 2019;30:113-120.

Schmit SL, Edlund CK, Schumacher FR, Gong J, Harrison TA, Huyghe JR, Qu C, Melas M, Van Den Berg DJ, Wang H, Tring S, Plummer SJ, Albanes D, Alonso MH, Amos CI, Anton K, Aragaki AK, Arndt V, Barry EL, Berndt SI, Bezieau S, Bien S, Bloomer A, Boehm J, Boutron-Ruault MC, Brenner H, Brezina S, Buchanan DD, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Castelao JE, Chan AT, Chang-Claude J, Chanock SJ, Cheng I, Cheng YW, Chin LS, Church JM, Church T, Coetzee GA, Cotterchio M, Cruz Correa M, Curtis KR, Duggan D, Easton DF, English D, Feskens EJM, Fischer R, FitzGerald LM, Fortini BK, Fritsche LG, Fuchs CS, Gago-Dominguez M, Gala M, Gallinger SJ, Gauderman WJ, Giles GG, Giovannucci EL, Gogarten SM, Gonzalez-Villalpando C, Gonzalez-Villalpando EM, Grady WM, Greenson JK, Gsur A, Gunter M, Haiman CA, Hampe J, Harlid S, Harju JF, Hayes RB, Hofer P, Hoffmeister M, Hopper JL, Huang SC, Huerta JM, Hudson TJ, Hunter DJ, Idos GE, Iwasaki M, Jackson RD, Jacobs EJ, Jee SH, Jenkins MA, Jia WH, Jiao S, Joshi AD, Kolonel LN, Kono S, Kooperberg C, Krogh V, Kuehn T, Küry S, LaCroix A, Laurie CA, Lejbkowicz F, Lemire M, Lenz HJ, Levine D, Li CI, Li L, Lieb W, Lin Y, Lindor NM, Liu YR, Loupakis F, Lu Y, Luh F, Ma J, Mancao C, Manion FJ, Markowitz SD, Martin V, Matsuda K, Matsuo K, McDonnell KJ, McNeil CE, Milne R, Molina AJ, Mukherjee B, Murphy N, Newcomb PA, Offit K, Omichessan H, Palli D, Cotoré JPP, Pérez-Mayoral J, Pharoah PD, Potter JD, Qu C, Raskin L, Rennert G, Rennert HS, Riggs BM, Schafmayer C, Schoen RE, Sellers TA, Seminara D, Severi G, Shi W, Shibata D, Shu XO, Siegel EM, Slattery ML, Southey M, Stadler ZK, Stern MC, Stintzing S, Taverna D, Thibodeau SN, Thomas DC, Trichopoulou A, Tsugane S, Ulrich CM, van Duijnhoven FJB, van Guelpan B, Vijai J, Virtamo J, Weinstein SJ, White E, Win AK, Wolk A, Woods M, Wu AH, Wu K, Xiang YB, Yen Y, Zanke BW, Zeng YX, Zhang B, Zubair N, Kweon SS, Figueiredo JC, Zheng W, Marchand LL, Lindblom A, Moreno V, Peters U, Casey G, Hsu L, Conti DV, Gruber SB. Novel Common Genetic Susceptibility Loci for Colorectal Cancer. J Natl Cancer Inst 2019;111:146-57.

Beaber EF, Sprague BL, Tosteson ANA, Haas JS, Onega T, Schapira MM, McCarthy AM, Li CI, Herschorn SD, Lehman CD, Wernli KJ, Barlow WE. Multilevel predictors of continued adherence to breast cancer screening among women ages 50-74 in a screening population. J Women’s Health, 2019;28:1051-1059.

2018

Rosenthal EA, Shirts BH, Amendola LM, Horlke-Pyne M, Robertson PD, Hisama FM, Bennett RL, Dorschner MO, Nickerson DA, Stanaway IB, Nassir R, Vickers KT, Li CI, Grady WM, Peters U, Jarvik GP. Rare loss of function variants in candidate genes and risk of colorectal cancer. Human Genetics 2018;137:795-806.

Flanagan MR, Tang M-T, Baglia ML, Porter P, Malone KE, Li CI. Relationship between anthropometric factors and risk of second breast cancer events among women with a history of ductal carcinoma in situ. JNCI Cancer Spectrum 2018;2:pky020.

Buas MF, Li CI, Anderson GL, Pepe MS. Recommendation to use exact p-values in biomarker discovery research. Cancer Epidemiology 2018;56:83-89.

Baglia ML, Cook LS, Tang M-T, Wiggins C, Hill D, Porter P, Li CI. Alcohol, smoking, and risk of HER2-overexpressing and triple-negative breast cancer relative to ER+ breast cancer. Int J Cancer 2018;143:1849-57.

McCarthy AM, Barlow W, Conant E, Haas J, Li CI, Sprague B, Armstrong K. Breast cancer with a poor prognosis diagnosed after screening mammography with negative results. JAMA Oncology 2018;4:998-1001.

Baglia ML, Tang M-T, Malone KE, Porter P, Li CI. Family history and risk of second primary cancer after in situ breast carcinoma. Cancer Epidemiol Biomarker Prev 2018;27:315-20.

2017

Baglia ML, Malone KE, Tang M-T, Li CI. Alcohol Intake and Risk of Breast Cancer by Histologic Subtype and Estrogen Receptor Status Among Women Aged 55 to 74 Years. Hormones and Cancer 2017;8:211-18.

Chen L, Chubak J, Boudreau DM, Barlow WE, Weiss, NS, Li CI. Diabetes treatments and risks of adverse breast cancer outcomes among early stage breast cancer patients: A SEER-Medicare analysis. Cancer Research 2017;77:6033-41.

Chen L, Chubak J, Boudreau DM, Barlow WE, Weiss, NS, Li CI. Use of antihypertensive medications and risk of adverse breast cancer outcomes. Cancer Epidemiol Biomarker Prev 2017;26:1603-10.

Greenlee H, Strizich G, Lovasi FS, Kaplan RC, Biggs ML, Li CI, Richardon J, Burke GL, Fitzpatrick AL, Fretts AM, Psaty BM, Fried LP. Concordance with cancer and cardiovascular disease prevention guidelines reduces mortality among older adults. Am J Epidemiol 2017;186:1168-79.

Martinez ME, Gomez SL, Tao L, Cress R, Rodriguez D, Unkart J, Schwab R, Nodora JN, Cook L, Komenaka I, Li CI. Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic White women. Breast Cancer Res Treat, DOI: 10.1007/s10549-017-4389-z.

Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld L, McCaskill-Stevens W, Paskett ED. Charting the Future of Cancer Health Disparities Research: A Position Statement from the American Association for Cancer Research, the American Cancer Society, The American Society of Clinical Oncology, and the National Cancer Institute. CA Cancer J Clin 2017;67:353-61.

Kaplan RC, Strizich G, Aneke-Nash C, Dominguez-Islas C, Bůžková P, Strickler H, Rohan T, Pollak M, Kuller L, Kizer JR, Cappola A, Li CI, Psaty BM, Newman A. Insulin-like growth factor binding protein-1 and ghrelin predict health outcomes among older adults: CHS cohort. J Clin Enocrinol Metab 2017;102:267-78.

Garrison CB, Lastwika KJ, Zhang Y, Li CI, Lampe PD. Proteomic analysis, immune dysregulation, and pathway interconnections with obesity. J Proteome Res 2017;16:274-87.

Farias AJ, Ornelas I, Hohl S, Zeliadt S, Hansen R, Li CI, Thompson B. Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysis. Supportive Care in Cancer 2017;25:75-83.

2016

Richards MK, Li CI, Foti JL, Leu MG, Wahbeh GT, Shaw D, Libby AK, Melzer L, Goldin AB. Resource utilization after implementing a hospital-wide standardized feeding tube pathway. J Pediatr Surg 2016;51:1674-9.

Rho J, Ladd JJ, Li CI, Potter JD, Zhang Y, Shelley D, Shibata D, Coppola D, Yamada H, Toyoda H, Tada T, Kumada T, Brenner DE, Hanash SM, Lampe PD. Protein and glycomic plasma markers for early detection of adenoma and colon cancer. Gut 2016;doi: 10.1136/gutjnl-2016-312794.

Farias AJ, Hansen RN, Zeliadt SB, Ornelas IJ, Li CI, Thompson B. The association between out-of-pocket costs and adherence to adjuvant endocrine therapy among newly diagnosed breast cancer patients. Am J Clin Oncol 2016, Nov 23.

Chen L, Cook LS, Tang MC, Porter PL, Hill DA, Wiggins CL, Li CI. Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer. Breast Cancer Res Treat 2016;157:545-54.

Knerr S, Hohl SD, Molina Y, Neuhouser ML, Li CI, Coronado GD, Fullerton, SM, Thompson B. Engaging Study Participants in Research Dissemination at a Center for Population Health and Health Disparities. Progress in Community Health Partnerships: Research, Education, and Action, 2016;10:569-76.

Chen L, Li CI, Tang MC, Porter P, Hill DA, Wiggins CL, Cook LS. Reproductive factors and risk of luminal, HER2-overexpressing, and triple-negative breast cancer among multiethnic women. Cancer Epidemiol Biomarkers Prev, 2016;25:1297-304.

Pepe MS, Janes H, Li CI, Bossuyt PM, Feng Z, Hilden J. Early-phase studies of biomarkers: what target sensitivity and specificity might confer clinical utility? Clin Chem 2016;62:737-42.

Lowry SJ, Kapphahn K, Chlebowski R, Li CI. Alcohol use and breast cancer survival among participants in the Women’s Health Initiative. Cancer Epidemiol Biomarkers Prev 2016;25:1268-73.

Farias AJ, Hansen RN, Zeliadt SB, Ornelas I, Li CI, Thompson B. Factors associated with adherence to adjuvant endocrine therapy among privately insured and newly diagnosed breast cancer patients: a quantile regression analysis. J Managed Care and Specialty Pharmacy 2016;22:969-78.

2015

Chen L, Li CI. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status. Cancer Epidemiol Biomarkers Prev 2015 doi: 10.1158/1055-9965.EPI-15-0293.

Buas MF, Gu H, Djukovic D, Zhu J, Drescher CW, Urban N, Raftery D, Li CI. Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors. Gynecol Oncol 2015 doi: 10.1016/j.ygyno.2015.10.021.

Urban N, Hawley S, Janes H, Karlan BY, Berg CD, Drescher CW, Manson JE, Palomares MR, Daly MB, Wactawski-Wende J, O'Sullivan MJ, Thorpe J, Robinson RD, Lane D, Li CI, Anderson GL. Identifying post-menopausal women at elevated risk for epithelial ovarian cancer. Gynecol Oncol 2015;139:253-60.

Buas MF, Rho J-H, Chai X, Zhang Y, Lampe PD, Li CI. Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study. Breast Cancer Res Treat 2015;153:445-54.

Chen L, Malone KE, Li CI. Use of antihypertensive medications not associated with risk of contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer. Cancer Epidemiol Biomarkers Prev 2015;24:1423-26.

Mirus JE, Zhang Y, Li CI, Lokshin AE, Prentice RL, Hingorani SR, Lampe PD. Cross-species antibody microarray interrogation identifies a 3-protein panel of plasma biomarkers for early detection of pancreas cancer. Clin Cancer Res 2015;21:1764-71.

Pepe MS, Li CI, Feng Z. Improving the quality of biomarker discovery research: the right samples and enough of them. Cancer Epidemiol Biomarkers Prev 2015;24:944-50.

Rosenberg AR, Kroon L, Chen L, Li CI, Jones B. Insurance status and risk of cancer mortality among adolescents and young adults. Cancer 2015;121:1279-86.

2014

Lowry SJ, Malone KE, Cushing-Haugen KL, Li CI. The risk of breast cancer associated with specific patterns of migraine history. Cancer Causes Control 2014;25:1707-1715.

Chen L, Malone KE, Li CI. Bra wearing not associated with breast cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2014;23:2181-2185.

Chen L, Linden HM, Anderson BO, Li CI. Time trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage: a national population-based study. Breast Cancer Res Treat 2014;147:609-616

Beaber EF, Buist DSM, Barlow WE, Malone KE, Reed SD, Li CI. Recent oral contraceptive use by formulation and breast cancer risk among young women. Cancer Research 2014;74:4078-4089

Brauer HA, D’Arcy M, Libby TE, Thompson HJ, Yasui YY, Hamajima N, Li CI, Troester MA, Lampe PD. Dermcidin expression is associated with disease progression and survival among breast cancer patients. Breast Cancer Res Treat 2014;144:299-306.

Li CI, Daling JR, Haugen KL, Tang MTC, Porter PL, Malone KE. Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age. Breast Cancer Res Treat 2014:145:481-489.

Pocobelli G, Newcomb PA, Li CI, Cook LS, Barlow WE, Weiss NS. Fatal breast cancer risk in relation to use of unopposed estrogen and combined hormone therapy. Breast Cancer Res Treat 2014;145:439-447.

Beaber EF, Malone KE, Tang MC, Barlow WE, Porter PL, Daling JR, Li CI. Oral contraceptive use and breast cancer risk overall and by molecular subtype among young women. Cancer Epidemiol Biomarker Prev 2014;23:755-764.

Pepe MS, Janes H, Li CI. Net risk reclassification P values: Valid or misleading? J Natl Cancer Inst 2014;106:dju041.

Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LAG, Cronin KA. U.S. Incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst 2014;106:dju055.

Kawai M, Malone KE, Tang MC, Li CI. Height, body mass index (BMI), BMI change, and the risk of estrogen receptor-positive, HER2-positive, and triple-negative breast cancer among women ages 20 to 44 years. Cancer. 2014:120;1548-56.

Kawai M, Malone KE, Tang MC, Li CI. Active smoking and the risk of estrogen receptor-positive and triple-negative breast cancer among women ages 20 to 44 years. Cancer. 2014;120:1026-34.

2013

AACR Cancer Progress Report Writing Committee, Sawyers CL, Abate-Shen C, Anderson KC, Barker A, Baselga J, Berger NA, Foti M, Jemal A, Lawrence TS, Li CI, Mardis ER, Neumann PH, Pardoll DM, Prendergast GC, Reed JC, Weiner GJ. AACR Cancer Progress Report 2013. Clin Cancer Res 2013:19:S1-98.

Kaplan HG, Malmgren JA, Li CI, Calip GS. Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors. Breast Cancer Res Treat 2013;142:629-636.

McDougall JA, Malone KE, Daling JR, Haugen KL, Porter PL, Li CI. Long-term statin use and risk of ductal and lobular breast cancer among women 55-74 years of age. Cancer Epidemiol Biomarker Prev 2013:22:1529-37.

Li CI, Daling JR, Tang MC, Haugen KL, Porter PL, Malone KE. Use of anti-hypertensive medications and breast cancer risk among women 55-74 years of age. JAMA Internal Medicine 2013:173:1629-1637.

Ladd JJ, Chao T, Johnson MM, Qiu J, Chin A, Israel R, Pitteri S, Mao J, Wu M, Amon LM, McIntosh M, Li CI, Prentice RL, Disis N, Hanash SM. Autoantibody signatures involving glycolysis and splicesome proteins preceding a diagnosis of breast cancer among post-menopausal women. Cancer Research 2013;73:1502-1513.

Livaudais JC, Lacroix AZ, Chlebowski RT, Li CI, Habel LA, Simon MS, Thompson B, Erwin DO, Hubbell FA, Coronado G. Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the Women's Health Initiative. Cancer Epidemiol Biomarker Prev 2013;22:365-373.

Saltzman BS, Weiss BS, Sieh W, Fitzpatrick AL, McTiernan A, Daling JR, Li CI. Use of antihypertensive medications and breast cancer risk. Cancer Causes Control 2013;24:365-371.

Li CI, Beaber EF, Tang MC, Porter PL, Daling JR, Malone KE. Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age. Breast Cancer Res Treat 2013;137:579-587.

Semmens EO, Kopecky KJ, Grant E, Mathes RW, Nishi N, Sugiyama H, Moriwaki H, Sakata R, Soda M, Kasagi F, Yamada M, Fujiwara S, Akahoshi M, Davis S, Kodama K, Li CI. Relationship between anthropometric factors, radiation exposure, and colon cancer incidence in the Life Span Study cohort of atomic bomb survivors. Cancer Causes Control 2013;24:27-37.

Calip GS, McDougall JA, Wheldon MC, Li CI, DeRoos AJ. Evaluation of seasonality in the diagnosis of acute myeloid leukemia among adults in the United States, 1992-2008. British Journal of Haematology 2013;160:343-350.

2012

Collaborative Groups on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 2012;13:1141-51.

Quon BS, Psoter K, Mayer-Hamblett N, Aitken ML, Li CI, Goss CH. Disparities in access to lung transplantation for patients with cystic fibrosis by socioeconomic status. Am J Respiratory Critical Care Med 2012;186:1008-1013.

Li CI, Mirus JE, Zhang Y, Ramirez AB, Ladd JJ, Prentice RL, McIntosh M, Hanash SM, Lampe PD. Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women’s Health Initiative observational study. Breast Cancer Res Treat 2012;135:611-618.

Saltzman BS, Malone KE, McDougall JA, Daling JR, Li CI. Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer. Breast Cancer Res Treat 2012;135:849-855.

Livaudais JC, Li CI, John EM, Terry MB, Daly M, Buys SS, Habel L, Thompson B, Yanez D, LaCroix A, Coronado GD. Racial and ethnic differences in adjuvant hormonal therapy use. J Womens Health 2012;21:950-958.

Lu H, Ladd J, Feng Z, Wu M, Goodell V, Pitteri SJ, Li CI, Prentice R, Hanash SM, Disis ML. Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in pre-diagnostic breast cancer sera. Cancer Prevention Research 2012;5:1036-1043.

Phipps AI, Anderson GL, Cochrane BB, Li CI, Wactawski-Wende J, Ho GYF, O’Sullivan MJ, Newcomb PA. Migraine history, nonsteroidal anti-inflammatory drug use, and risk of postmenopausal endometrial cancer. Horm Cancer 2012; 3:240-248.

Pepe MS, Fan J, Seymour C, Li CI, Huang Y, Feng Z. Biases introduced by choosing controls to match risk factors of cases in biomarker research. Clin Chem 2012;58:1242-1251.

Banegas MP, Li CI. Breast cancer characteristics and outcomes among Hispanic Black and Hispanic White women. Breast Cancer Res Treat 2012;134:1297-1304.

Phipps AI, Buist DSM, Malone KE, Barlow WE, Porter PL, Kerlikowske K, O’Meara E, Li CI. Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol 2012;5:340-348.

Phipps AI, Scoggins J, Rossing MA, Li CI, Newcomb PA. Temporal trends in incidence and mortality rates for colorectal cancer by tumor location: 1975-2007. Am J Public Health 2012;102:1791-1797.

Li CI, Beaber EF, Tang MC, Porter PL, Daling JR, Malone KE. Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20-44 years of age. Cancer Research 2012; 72:2028-2035.

Amon LM, Pitteri SJ, Li CI, McIntosh M, Ladd J, Disis ML, Porter P, Wong C-H, Zhang Q, Lampe P, Prentice RL, Hanash SM. Concordant release of glycolysis proteins in plasma preceding a diagnosis of ER+ breast cancer. Cancer Research 2012;72:1935-42.

Livaudais JC, Hershman DL, Habel L, Kushi L, Gomez SL, Li CI, Neugut AI, Fehrenbacher L, Thompson B, Coronado GD. Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Res Treat 2012; 131:607-617.

Kwon S, Lazo-Escalante M, Villaran MV, Li CI. Relationship between interpregnancy interval and birth defects in Washington State. J Perinatol 2012;32:45-50.

2011

Monsees GM, Malone KE, Tang MC, Newcomb PA, Li CI. Bisphosphonate use following first primary ER+ breast cancer and risk of second primary breast cancer. J Natl Cancer Inst 2011;103:1752-60.

Kabat GC, Kim M, Phipps AI, Li CI, Messina C, Wactawski-Wende J, Kuller L, Simon M, Yasmeen S, Wassertheil-Smoller S, Rohan TE. Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women. Cancer Causes Control 2011; 22:775-783.

Phipps AI, Chlebowski RT, Prentice R,McTiernan A, Stefanick ML, Wactawski-Wende J, Kuller LH, Adams-Campell LL, Lane D, Vitolins M, Kabat GC, Rohan TE, Li CI. Body size, physical activity, and risk of triple-negative breast cancer in postmenopausal women. Cancer Epidemiol Biomarker Prev 2011;20:454-463.

Li CI. Discovery and validation of breast cancer early detection biomarkers in preclinical samples. Horm Cancer 2011; 2:125-131.

Huang Y, Malone KE, Cushing-Haugen KL, Daling JR, Li CI. Relationship between menopausal symptoms and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarker Prev 2011; 20:379-388.

Phipps AI, Buist DSM, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI. Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Cancer Causes and Control 2011; 22:399-405.

Ooi SW, Martinez ME, Li CI. Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat 2011;127:729-738.

Phipps AI, Chlebowski RT, Prentice R,McTiernan A, Wactawski-Wende J, Kuller LH, Adams-Campell LL, Lane D, Stefanick ML, Vitolins M, Kabat GC, Rohan TE, Li CI. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 2011;103:470-477.

Ton CC, Vartanian N, Chai S, Lin M-G, Yuan X, Lawton TL, Daling JR, Malone KE, Li CI, Dawson A, Cassandra S, Delrow J, Hsu L, Porter PL. Improvements in WG-DASL gene expression array testing of FFPE archival breast tumor samples. Breast Cancer Res Treat 2011; 125:879-883.

Phipps AI, Buist DSM, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI. First-degree family history of breast cancer and triple-negative breast cancer risk. Breast Cancer Res Treat 2011;136:671-678.

Voigt LF, Schwartz SM, Doody DR, Lee SC, Li CI. Feasibility of including cellular telephone numbers in random digit dialing for epidemiologic case-control studies. Am J Epidemiol 2011;173:118-126.

2010

Pitteri SJ, Amon LM, Buson TB, Zhang Y, Johnson MM, Chin A, Kennedy J, Wong C-H, Zhang Q, Wang H, Lampe PD, Prentice RL, McIntosh MW, Hanash SM, Li CI. Elevated plasma levels of epidermal growth factor receptor prior to the diagnosis of breast cancer. Cancer Research 2010;70:8598-606.

Li CI, Nishi N, McDougall JA, Semmens EO, Sugiyama H, Soda M, Sakata R, Hayashi M, Kasagi F, Suyama A, Mabuchi K,Davis S, Kodama K, Kopecky KJ. Relationship between radiation exposure and risk of second primary cancers among atomic bomb survivors. Cancer Research 2010;70:7187-7198.

Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, Lessin L, O’Sullivan MJ, Wactawski-Wende J, Yasmeen S, Prentice R. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the Women’s Health Initiative Observational Study. J Natl Cancer Inst, 2010;102:1422-1431.

Li CI, Daling JR, Tang MC, Malone KE. Relationship between diabetes and risk of second primary contralateral breast cancer. Breast Cancer Res Treat, 2010;125:545.

Li CI. Risk of mortality by histologic type of breast cancer in the United States, 2000-2006. Hormones and Cancer 2010;1:156-165.

Phipps AI, Li CI, Kerlikowske K, Barlow WE, Buist DSM. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population. Cancer Epidemiol Biomarker Prev 2010;19:1643-54.

McDougall JA, Sakata R, Sugiyama H, Grant EJ, Davis S, Nishi N,Soda M, Shimizu Y, Tatsukawa Y,Kasagi F,Suyama A,Ross P, Kopecky KJ, Li CI. Timing of menarche and first birth in relation to risk of breast cancer in A-bomb survivors. Cancer Epidemiol Biomarker Prev 2010;19:1755-65.

Li CI, Mathes RW, Bluhm EC, Caan B, Cavanagh M, Chlebowski RT, Michael Y, O’Sullivan MJ, Prentice R. Migraine history and breast cancer risk among postmenopausal women. J Clin Oncol 2010;28:1005-1010.

McDougall JA, Li CI. Trends in distant stage breast, colorectal, and prostate cancer incidence rates from 1992-2004. Hormones and Cancer 2010;1(1):55-62.

Reichman ME, Altekruse S, Li CI, Chen VW, Deapen D, Potts M, Wu XC, Morrell D, Hafterson J, Phipps AI, Harlan LC, Ries LG, Edwards BK. Feasibility study for collection of HER2 data by NCI Surveillance, Epidemiology and End Results (SEER) Program central cancer registries. Cancer Epidemiol Biomarker Prev 2010;19:144-7.

2009

Reding KW, Li CI, Weiss NS, Chen C, Carlson CS, Duggan D, Thummel KE, Daling JR, Malone KE. Genetic Variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk. Am J Epidemiol 2009;170:1241-49.

Li CI, Daling JR, Porter PL, Tang MC, Malone KE. Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor positive invasive breast cancer. J Clin Oncol 2009;27:5312-18.

Li CI, Daling JR, Porter PL, Tang MC, Malone KE. Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer. Cancer Research 2009;69:6865-70.

Li CI, Mathes RW, Malone KE, Daling JR, Bernstein L, Marchbanks PA, Strom BL, Simon MS, Press MF, Deapen D, Burkman RT, Folger SG, McDonald JA, Spirtas R. Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal women. Cancer Epidemiol Biomarker Prev 2009;18:2030-2034.

Reding KW, Weiss NS, Chen C, Li CI, Carlson CS, Wilkerson H-W, Farin FM, Thummel KE, Daling JR, Malone KE. Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk. Cancer Epidemiol Biomarker Prev 2009;18:1461-1467.

Shah CA, Goff BA, Lowe K, Peters WA, Li CI. Factors affecting risk of mortality in women with vaginal cancer. Obstetrics & Gynecology 2009;113:1038-45.

Pierce BL, Biggs ML, DeCambre M, Reiner AP, Li CI, Fitzpatrick A, Carlson CS, Stanford J, Austin MA. C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older. Cancer Causes Control 2009;20:1193-203.

Welsh ML, Buist DSM, Bowles EJA, Anderson ML, Elmore JG, Li CI. Breast cancer risk and tumor subtype in relation to family history of breast cancer in a population-based setting. Breast Cancer Res Treat 2009;114:549-558.

2008

Beaber EF, Holt VL, Malone KE, Porter PL, Daling JR, Li CI. Reproductive factors, age at maximum height, and risk of three histologic types of breast cancer. Cancer Epidemiol Biomarker Prev 2008;17:3427-34.

Mathes RW, Malone KE, Daling JR, Davis S, Lucas SM, Porter PL, Li CI. Migraine in post-menopausal women and the risk of invasive breast cancer. Cancer Epidemiol Biomarker Prev 2008;17:3116-22.

Loo LWM, Ton C, Wang Y-W, Grove DI, Bouzek H, Vartanian N, Lin M-G, Yuan X, Lawton TL, Daling JR, Malone KE, Li CI, Hsu L, Porter PL. Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer. Genes Chromosomes Cancer 2008;47:1049-1066.

Phipps AI, Malone KE, Porter PL, Daling JR, Li CI. Reproductive and hormonal risk factors for postmenopausal luminal, HER2-overexpressing, and triple-negative breast cancer. Cancer 2008;113:1521-1526.

Phipps AI, Malone KE, Porter PL, Daling JR, Li CI. Body size and risks of luminal, HER2-overexpressing, and triple-negative breast cancer among postmenopausal women. Cancer Epidemiol Biomarker Prev 2008;17:2078-2086.

Mathes RW, Malone KE, Daling JR, Porter PL, Li CI. Relationship between histamine₂-receptor antagonist medications and risk of invasive breast cancer. Cancer Epidemiol Biomarker Prev 2008;17:67-72.

Li CI, Malone KE, Porter PL, Lawton TJ, Voigt LF, Cushing-Haugen KL, Lin MG, Yuan X, Daling JR. Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas. Cancer Epidemiol Biomarker Prev 2008;17:43-50.

Li CI, Malone KE, Daling JR, Potter JD, Bernstein L, Marchbanks PA, Strom BL, Simon MS, Press MF, Ursin G, Burkman RT, Folger SG, Norman S, McDonald JA, Spirtas R. Timing of menarche and first full-term birth in relation to breast cancer risk. Am J Epidemiol 2008;167:230-239.

2007

Li CI, Daling JR. Changes in breast cancer incidence rates in the United States by histological subtype and race/ethnicity, 1995-2004. Cancer Epidemiol Biomarker Prev 2007;16:2773-2780.

Blume HK, Li CI, Loch CM, Koepsell TD. Fever, chorioamnionitis and the risk of neonatal encephalopathy: a case-control study in Washington State. Developmental Med Child Neuro 2008;50:19-24.

McDougall JA, Madeleine MM, Daling JR, Li CI. Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003. Cancer Causes Control 2007;18:1175-1186.

Li CI, Littman AJ, White E. Relationship between age maximum height is attained, age at menarche, and age at first full-term birth and breast cancer risk. Cancer Epidemiol Biomarker Prev 2007;16:2144-2149.

Dunnwald LK, Rossing MA, Li CI. Differences in survival by hormone receptor status and varying tumor characteristics among women with invasive breast carcinoma. Breast Cancer Res Treat 2007;9:R6.

Blume HK, Loch CM, Li CI. Neonatal encephalopathy and socioeconomic status: a population-based case-control study. Arch Pediatrics Adolescent Med 2007;161:663-668.

Sun L-M, Li CI, Huang E-Y, Vaughan T. Survival differences by race in nasopharyngeal carcinoma. Am J Epidemiol 2007;165:271-278.

2006

Li CI. Risk of invasive breast cancer among ductal carcinoma in situ and lobular carcinoma in situ patients. Am J Hematology/Oncology 2006;5:1-6.

Li CI. Clinical characteristics of different histological types of invasive breast cancer. Current Medical Literature: Breast Cancer 2006;18:33-39.

Wright JL, Porter MP, Li CI, Lange PH, Lin DW. Differences in survival among patients with urachal and non-urachal adenocarcinomas of the bladder. Cancer 2006;721-728.

Li CI, Daling JR, Malone KE, Bernstein L, Marchbanks PA, Liff JM, Strom BL, Simon MS, Press MF, McDonald JA, Ursin G, Burkman RT, Deapen D, Spirtas R. Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer. Cancer Epidemiol Biomarker Prev 2006;15:946-954.

Li CI, Malone KE, Daling JR. Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk. Cancer Causes Control 2006;17:695-703.

Li CI, Malone KE, Saltzman BS, Daling JR. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001. Cancer 2006;106:2104-2112.

Chien C, Li CI, Heckbert SR, Malone KE, Boudreau DM, Daling JR. Antidepressant use and breast cancer risk. Breast Cancer Res Treat 2006;95:131-140.

2005

Sun L-M, Epplein M, Li CI, Vaughan T, Weiss NS. Trends in the incidence rates of nasopharyngeal carcinoma among Chinese Americans. Am J Epidemiol 2005;162:1174-1178.

Li CI, Uribe DJ, Daling JR. Clinical and pathologic characteristics of different histologic types of breast cancer. Brit J Cancer 2005;93:1046-1052.

Li CI, Malone KE, Daling JR. The relationship between various measures of cigarette smoking and risk of breast cancer among women 65-79 years of age. Cancer Causes Control 2005;16:975-985.

Fesinmeyer MD, Austin MA, Li CI, DeRoos AJ, Bowen DJ. Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomarker Prev 2005;14:1766-1773.

Chien C, Morimoto LM, Tom J, Li CI. Differences in colorectal cancer stage and survival by race and ethnicity. Cancer 2005;104:629-639.

Li CI. Racial and ethnic disparities in breast cancer stage, treatment and survival in the United States. Ethnicity & Disease 2005;15:S2-5-S2-9.

Li CI, Malone KE, Daling JR. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980-2001. Cancer Epidemiol Biomarker Prev 2005;14:1008-1011.

Mitchell BL, Yasui Y, Li CI, Fitzpatrick AL, Lampe PD. Impact of freeze-thaw cycles and storage time on plasma samples used in mass spectrometry based biomarker discovery projects. Cancer Informatics 2005;1:25-31

2004

Li CI. Postmenopausal hormone therapy and the risk of breast cancer: The view of an epidemiologist. Maturitas 2004;49:44-50.

Loo LWM, Grove DI, Neal CL, Williams EM, Cousens LA, Schubert EL, Holcomb IN, Massa H, Glogovac J, Li CI, Malone KE, Daling JR, Delrow JJ, Trask BJ, Hsu L, Porter PL. Array CGH analysis of genomic alterations in breast cancer sub-types. Cancer Res 2004;64:8541-8549.

2003

Li CI. The relationship between HRT and breast cancer risk: past, present, and future. Current Medical Literature: Breast Cancer 2003;15:91-97.

Li CI, Malone KE, Porter PL, Weiss NS, Tang MC, Daling JR. The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65-79 years of age. Cancer Epidemiol Biomarker Prev 2003;12:1061-6.

Li CI, Moe RE, Daling JR. Risk of mortality by histologic type of breast cancer. Arch Intern Med 2003;163:2149-53.

Li CI, Malone KE, Porter PL, Weiss NS, Tang MC, Daling JR. Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age. Int J Cancer 2003;107:647-51.

Li CI, Malone KE, Weiss NS, Boudreau DM, Cushing-Haugen KL, Daling JR. The relationship between use of antihypertensive medications and risk of breast cancer among women 65-79 years of age. Cancer 2003;98:1504-13.

Li CI, Malone KE, Porter PL, Daling JR. Epidemiologic and molecular risk factors for contralateral breast cancer among women diagnosed with a first breast cancer before age 45. Brit J Cancer 2003;89:513-518.

Li CI, Malone KE, Porter PL, Weiss NS, Tang MC, Cushing-Haugen KL, Daling JR. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA 2003;289:3254-3263.

Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 2003;289:1421-1424.

Li CI, Daling JR, Emanuel I. Birthweight and risk of overall and cause-specific childhood mortality. Paediatric Perinatal Epidemiol 2003;17:164-170.

Li CI, Daling JR, Malone KE. Incidence of invasive breast cancer by hormone receptor status from 1990 to 1998. J Clin Oncol 2003 ;21 :28-34.

Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 2003;163:49-56.

2002

Li CI, Anderson BO, Daling JR, Moe RE. Changing incidence of lobular carcinoma in situ of the breast. Breast Cancer Res Treat 2002;75:259-268.

Li CI, Malone KE, Daling JR. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarker Prev 2002;11: 601-607.

2001

Li CI, Malone KE, Weiss NS, Daling JR. Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst 2001;93:1008-1013.

2000

Li CI, Rossing MA, Voigt LF, Daling JR. Multiple primary breast and thyroid cancers: role of age at diagnosis and cancer treatments. Cancer Causes Control 2000;11:805-811.

Li CI, Stanford JL, Daling JR. Anthropometric variables in relation to risk of breast cancer in middle-aged women. Int J Epidemiol 2000 ;29 :208-213.

Li CI, Weiss NS, Stanford JL, Daling JR. Hormone replacement therapy in relation to risk of lobular and ductal breast cancer in middle-aged women. Cancer 2000;88:2570-2577.

Li CI, Anderson BO, Porter P, Holt SK, Daling JR, Moe RE. Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer 2000;88:2561-2569.

1998

van Oers HJJ, de Kloet ER, Li C, Levine S. The ontogeny of glucocorticoid negative feedback: influence of maternal deprivation. Endocrinology 1998;139:2838-2846.

1997

Li CI, Malone KE, White E, Daling JR. Age when maximum height is reached as a risk factor for breast cancer among young U.S. women. Epidemiology 1997;8:559-565.

1994

Li SA, Xue Y, Xie Q, Li CI, Li JJ. Serum and tissue levels of estradiol during estrogen-induced renal tumorigenesis in the Syrian hamster. J Steroid Biochem Biol 1994;48:283-286.

Fred Hutchinson Cancer Center | 1100 Fairview Ave. N., Seattle, WA 98109
© 2025 Fred Hutchinson Cancer Center, a 501(c)(3) nonprofit organization.

Li Lab